The latest molecular studies have provided quite a few insights to the processes that govern the event and development of CLL, together with quite a few novel mutated genes clustered in numerous functional pathways. The CLL epigenome is reprogrammed from the modulation of regulatory areas that show up de novoand IGHV hold the strongest impact on a